Biomarkers in Swiss Multiple Sclerosis Cohort (SMSC) and large studies
Determinants of Brain Atrophy in Multiple Sclerosis
Treatment effects of Brain Atrophy and Lesion changes in Multiple Sclerosis
Brain Repair in Multiple Sclerosis: location and clinical correlates
Diagnostic value of CVS and cortical lesions for MS diagnosis (MAGNIMS)
Spinal cord Atrophy as prognostic tool in Multiple Sclerosis
This page is under construction.
- PD Dr Katrin Parmar
- Dr Athina Papadopoulou
- PD Dr Regina Schläger
- PD Dr Özgür Yaldizli
- Prof Dr Cristina Granziera